Revvity/Honeycomb Biotechnologies Hive CLX Single-Cell RNAseq Solution, BeeNetPlus, Hive CLX Service

Revvity and Honeycomb Biotechnologies have commercially launched the Hive CLX Single-Cell RNAseq solution for sample storage and single-cell profiling, BeeNetPlus analysis workflow, and Hive CLX service for shipping cells to Honeycomb for processing, sequencing, and analysis. Revvity said the Hive CLX Single-Cell RNAseq solution is an upgrade of the portable platform launched by the companies in 2021. It provides higher-density single-cell capture and integrated sample storage in an instrument-free workflow that can be implemented into studies of rare and fragile cell types or of the immune system, among other applications. The BeeNetPlus cloud-based analysis workflow aids interpretation of Hive CLX results by providing reports on sequencing quality, cell type annotation, differential expression, marker gene plots, and cell, gene, and transcripts recovery. The Hive CLX service, available in the US, provides sample-to-result concierge services for single-cell research.